4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Critical Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benowitz, NL; Bernard, GR; Calfee, CS; Havel, C; Jacob, P; Janz, DR; Kangelaris, KN; Matthay, MA; May, AK; Siew, ED; Ware, LB | 1 |
| Benowitz, NL; Calfee, CS; Eisner, MD; Goniewicz, ML; Havel, C; Hsieh, SJ; Jacob, P; Matthay, MA; Ware, LB; Yu, L | 1 |
2 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Critical Illness
| Article | Year |
|---|---|
Cigarette Smoke Exposure and the Acute Respiratory Distress Syndrome.
Topics: Adult; Aged; Alcoholism; APACHE; Biomarkers; Critical Illness; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Nitrosamines; Prevalence; Prospective Studies; Pyridines; Racial Groups; Respiratory Distress Syndrome; Risk Factors; Sepsis; Smoking; Tertiary Care Centers; Time Factors; Tobacco Smoke Pollution | 2015 |
Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients.
Topics: Academic Medical Centers; Adult; Aged; Biomarkers; Cohort Studies; Cotinine; Critical Illness; Female; Humans; Male; Middle Aged; Nitrosamines; Prevalence; Pyridines; Reference Values; Risk Assessment; Sensitivity and Specificity; Smoking; Statistics, Nonparametric; Tennessee; Tobacco Smoke Pollution | 2011 |